Edition:
United Kingdom

People: PTC Therapeutics Inc (PTCT.OQ)

PTCT.OQ on NASDAQ Stock Exchange Global Select Market

34.67USD
11 Dec 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$34.67
Open
$34.96
Day's High
$35.00
Day's Low
$34.14
Volume
129,778
Avg. Vol
296,173
52-wk High
$52.95
52-wk Low
$15.60

Utter, Christine 

Ms. Christine Utter serves as Principal Financial Officer, Treasurer of the Company since June 2017. Ms. Utter joined the Company in 2010 as the Assistant Controller and became Senior Vice President, Finance, in January 2017. From 2005 until 2009, Ms. Utter was the Assistant Corporate Controller of Barrier Therapeutics, a pharmaceutical company. Prior to 2005, Ms. Utter held positions as a financial analyst at Engelhard Corporation and as an auditor at both Ernst & Young LLP and Arthur Andersen. Ms. Utter holds a B.S. in accounting from The College of New Jersey, and is a certified public accountant.

Basic Compensation

Total Annual Compensation, USD 484,663
Restricted Stock Award, USD 43,797
Long-Term Incentive Plans, USD --
All Other, USD 342,281
Fiscal Year Total, USD 870,741

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Michael Schmertzler

242,177

Stuart Peltz

2,172,680

Christine Utter

870,741

Marcio Souza

1,524,270

Neil Almstead

951,918

Mark Boulding

1,121,910
As Of  31 Dec 2017